Exploring the Preferences of the Australian Public for Antibiotic Treatments: A Discrete Choice Experiment-Reference-Cited by-同舟云学术

Exploring the Preferences of the Australian Public for Antibiotic Treatments: A Discrete Choice Experiment

Published:2023-07-18 Issue:5 Volume:16 Page:555-567
ISSN:1178-1653
Container-title:The Patient - Patient-Centered Outcomes Research
language:en
Short-container-title:Patient

Author:

Degeling Chris^ORCID,Yarwood Trent^ORCID,Nettel-Aguirre Alberto^ORCID,Mullan Judy^ORCID,Reynolds Nina,Chen Gang^ORCID

Funder

University of Wollongong

The University of Wollongong

Publisher

Springer Science and Business Media LLC

Subject

General Engineering

Link

https://link.springer.com/content/pdf/10.1007/s40271-023-00640-z.pdf

Reference43 articles.

1. Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022 2022/01/19/.

2. O’Neill J. Tackling drug-resistant infections globally final report and recommendations. London: Wellcome Trust & HM Government; 2016.

3. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study. The Lancet. 2020;395(10219):200–11.

4. Ikuta KS, Swetschinski LR, Robles Aguilar G, Sharara F, Mestrovic T, Gray AP, et al. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2022;400(10369):2221–48.

5. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–98.